Fig. 3: Paired αβ TCR repertoire of NP105–113-B*07:02-specific T cells from convalescent patients with COVID-19. | Nature Immunology

Fig. 3: Paired αβ TCR repertoire of NP105–113-B*07:02-specific T cells from convalescent patients with COVID-19.

From: An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Fig. 3

a, Circos plots for each patient depicting αβ VJ gene usage: two patients with mild disease (C-COV19-005 and C-COV19-046) and two with severe symptoms (C-COV19-045 and C-COV19-038). b, Circos plot to show TCR clonotypes for all patients (clonotype defined as patient-specific V-gene usage and CDR3 amino acid sequence for Vα and Vβ). Each line represents a unique clonotype. Clonotypes that have dominant Vβ gene usage (TRBV5-1, TRBV28, TRBV27 and TRBV24) are highlighted; all others are shown in gray.

Back to article page